Shrimp Disease Diagnostics Market Size, Share, Growth, and Industry Analysis, By Types (WSSV (White Spot Syndrome Virus), TSV (Taura Syndrome Virus), YHV/GAV (Yellow Head/Gill Associated Virus)), By Applications Covered (Fisheries, Aquaculture Laboratories), Regional Insights and Forecast to 2033

Shrimp Disease Diagnostics Market Size

The Shrimp Disease Diagnostics Market size was USD 189.65 Million in 2024 and is projected to touch USD 213.5 Million in 2025 to USD 550.87 Million by 2033, exhibiting a CAGR of 12.58% during the forecast period [2025-2033]. This double-digit CAGR highlights the strong market momentum, fueled by increasing disease outbreaks, technological advancements in molecular diagnostics, and the growing need for shrimp health management solutions across key aquaculture regions, particularly in Asia-Pacific and Latin America.

The U.S. shrimp disease diagnostics market holds nearly 8% share globally, driven by advanced aquaculture practices. Over 50% of U.S. shrimp farms utilize molecular diagnostic tools, while 45% implement strict biosecurity protocols, ensuring early detection, improved shrimp health, and sustainable seafood production.

Key Findings

• Market Size: Valued at 213.5M in 2025, expected to reach 550.87M by 2033, growing at a CAGR of 12.58% during the forecast period.
• Growth Drivers: Over 65% of shrimp farming operations depend on diagnostics, with 55% adopting early disease detection and 40% improving biosecurity practices.
• Trends: More than 45% of the market focuses on PCR solutions, 35% on point-of-care kits, and 38% on multi-pathogen detection technologies.
• Key Players: Thermo Fisher Scientific, GeneReach Biotechnology Corp., Speedy Assay Sdn Bhd, Auro Biotechnologies, SUREBIO.
• Regional Insights: Asia-Pacific leads with 60% market share, followed by Latin America at 20%, North America at 12%, Europe at 6%, and Middle East & Africa at 2%, driven by shrimp farming density, biosecurity measures, and diagnostic adoption rates.
• Challenges: Around 42% of small farmers face cost barriers, 35% lack technical skills, and 33% have limited infrastructure for diagnostics.
• Industry Impact: Over 55% reduction in shrimp mortality achieved through diagnostics, with 50% of farmers improving production quality and 45% enhancing exports.
• Recent Developments: More than 30% of manufacturers launched new kits, 28% formed partnerships, and 25% introduced portable solutions targeting small and medium farms.

Would you like the content prepared in an editable document?

The shrimp disease diagnostics market is expanding rapidly due to the increasing demand for disease-free shrimp across global aquaculture farms. With over 65% of the shrimp supply depending on intensive aquaculture, disease management has become critical. More than 70% of shrimp farmers now prioritize early diagnosis to prevent large-scale losses. Asia-Pacific holds around 58% share in shrimp farming, leading the adoption of diagnostics technologies. The market is further driven by the need to control viral infections, which account for over 60% of disease-related shrimp mortality globally. This rising demand for fast, accurate, and cost-effective diagnostics is pushing the market forward.

Shrimp Disease Diagnostics Market Trends

The shrimp disease diagnostics market is witnessing notable advancements in testing technologies, with PCR-based solutions accounting for over 45% of the market share in 2024. Loop-mediated isothermal amplification (LAMP) techniques follow closely with a 32% share due to their ease of use and faster results. Over 50% of shrimp farmers have adopted molecular diagnostic tools to manage disease outbreaks more effectively. Biosecurity implementation has increased by 40% across farms, directly impacting the demand for regular diagnostic checks. Affordable diagnostic kits account for 38% of the product demand, especially in emerging shrimp-producing nations.

In regional terms, Asia-Pacific remains dominant with nearly 60% of the market share, followed by Latin America at 20% and North America at 12%. Within Asia-Pacific, Vietnam and India collectively represent 48% of the regional demand. Viral disease detection, specifically targeting White Spot Syndrome Virus (WSSV) and Taura Syndrome Virus (TSV), constitutes 55% of the diagnostic focus. Point-of-care diagnostic solutions now represent 35% of the total market due to their growing acceptance in small to medium-scale shrimp farms. Furthermore, partnerships between manufacturers and research institutions have grown by 28% in the last two years, accelerating product development and market adoption.

Shrimp Disease Diagnostics Market Dynamics

OPPORTUNITY

Rising Adoption of Point-of-Care Testing Kits

The growing demand for affordable and easy-to-use diagnostic kits offers significant market potential. Point-of-care testing kits now account for 35% of total market demand due to their simplicity and low cost. Over 48% of shrimp farmers in developing countries prefer these solutions for onsite diagnosis. Manufacturers focusing on portable kits have seen a 30% rise in market interest. The integration of mobile apps and digital tools for result interpretation has grown by 28%, further enhancing user experience. Targeting emerging markets, where over 40% of shrimp farms operate without sophisticated labs, presents untapped potential for diagnostic providers.

DRIVERS

Increasing Shrimp Farming Activities

The shrimp disease diagnostics market is strongly driven by the expansion of shrimp farming, which accounts for over 65% of the global seafood supply. Rising disease outbreaks have impacted nearly 52% of shrimp farms, forcing producers to prioritize diagnostics. More than 55% of the market demand comes from early disease detection efforts. Biosecurity programs have increased by 40% globally, requiring constant pathogen monitoring. Technological adoption in molecular diagnostics like PCR and LAMP has grown by 45%, enabling rapid detection of pathogens. The growing awareness of economic losses, which impact nearly 48% of shrimp exports, is also driving market demand.

RESTRAINT

"High Cost of Advanced Diagnostic Solutions"

The shrimp disease diagnostics market faces restrictions due to the high costs of advanced molecular diagnostic tools, limiting their adoption to just 42% of small-scale farmers. More than 37% of shrimp producers in low-income regions struggle with affordability. Lack of technical expertise affects around 35% of aquaculture operations, reducing the usage of complex diagnostic platforms. Infrastructure limitations impact over 33% of rural farms, where access to diagnostic labs is minimal. Traditional methods are still used by nearly 40% of farmers due to cost concerns, slowing the adoption of high-tech solutions in certain regions, especially in small and medium enterprises.

CHALLENGE

"Limited Awareness and Training in Disease Management"

Limited awareness and inadequate training remain key challenges in the shrimp disease diagnostics market. Around 38% of shrimp farmers lack knowledge of advanced diagnostic methods. Training adoption rates are below 42% in rural and semi-urban areas. More than 33% of farmers rely on visual inspections, increasing the risk of late disease detection. Diagnostic companies face difficulties in reaching nearly 35% of small and unorganized farms. Language barriers and the lack of localized training content impact over 30% of end users, limiting technology penetration and proper disease management practices, especially in fragmented shrimp farming sectors.

Segmentation Analysis

The shrimp disease diagnostics market is segmented by type and application, addressing specific pathogen detection needs and user environments. By type, viral and bacterial disease diagnostics dominate, accounting for over 60% of the total market share. WSSV and TSV lead the demand, contributing 45% and 30% respectively. By application, aquaculture laboratories and fisheries represent 50% of market usage due to their routine health monitoring practices. Marine laboratories account for 20%, while education and research institutes cover 15% of the market. This segmentation highlights the market's wide application scope across various professional and academic environments globally.

By Type

• WSSV (White Spot Syndrome Virus): WSSV diagnostics account for 45% of the market due to the virus's high mortality impact, affecting over 50% of global shrimp farms. Early detection solutions have grown by 40% in response to frequent outbreaks.
• TSV (Taura Syndrome Virus): TSV detection holds a 30% share, driven by its prevalence in the Americas and Asia. PCR-based kits for TSV have increased in demand by 35%, aiding shrimp farmers in preventing large-scale losses.
• YHV/GAV (Yellow Head/Gill Associated Virus): YHV/GAV diagnostics represent 12% of the market, primarily in Southeast Asia. Adoption of LAMP technology for YHV/GAV has increased by 28% due to faster detection capabilities.
• IHHNV (Infectious Hypodermal and Hematopoietic Virus): IHHNV accounts for 8% of the market, with farmers increasingly adopting diagnostic kits to manage chronic infections, which impact nearly 15% of shrimp yields.
• HPV (Hepatopancreatic Parvovirus): HPV diagnostics hold a 5% market share, with targeted screening solutions growing by 12% among large aquaculture operations to ensure broodstock health.
• EMS (Early Mortality Syndrome): EMS diagnostics contribute 18%, as this bacterial disease affects nearly 25% of farms globally. PCR-based solutions for EMS detection have grown by 20% in the last two years.
• EHP (Enterocytozoon hepatopenaei): EHP represents 10% of the diagnostics market, with microscopy and molecular tests gaining 15% more usage due to its impact on shrimp growth and performance.
• Others: Other disease diagnostics make up 5%, covering less common pathogens. These specialized kits have seen a 7% increase in niche market demand.

By Application

• Fisheries: Fisheries account for 35% of the market as large-scale operators prioritize disease prevention to secure exports. Over 40% of fisheries use molecular diagnostic methods.
• Aquaculture Laboratories: Aquaculture laboratories represent 30%, driven by routine monitoring requirements. More than 45% of these labs utilize PCR and LAMP technologies.
• Marine Laboratories: Marine laboratories hold a 20% share, focusing on environmental screening and disease management programs, with a 25% increase in advanced tool usage.
• Education and Research Institutes: Education and research institutes account for 10%, contributing to 15% of the research and development activities on shrimp disease diagnostics.
• Others: Other applications, including private consultancy services, make up 5%, with a 12% rise in demand for tailored diagnostic solutions for small-scale operations.

Regional Outlook

The shrimp disease diagnostics market shows significant regional diversity, with Asia-Pacific dominating at 60% of the global share. Latin America follows with 20%, supported by large shrimp farming activities in Ecuador and Mexico. North America holds 12%, focusing on advanced diagnostic research. Europe contributes 6%, emphasizing sustainability and regulatory compliance. The Middle East & Africa represents 2%, with growing aquaculture investments. Regional initiatives to boost shrimp farming and disease management programs are expanding, with over 35% of new diagnostic product launches targeting Asia-Pacific and Latin America due to their high market concentration and disease incidence rates.

North America 

North America accounts for 12% of the global shrimp disease diagnostics market, supported by advanced aquaculture practices and research initiatives. The United States dominates the regional market with nearly 8% share, driven by its focus on sustainable seafood production. Over 50% of shrimp farms in the U.S. adopt molecular diagnostics like PCR for early disease detection. Canada contributes around 3%, mainly from aquaculture research centers promoting biosecurity measures. Mexico holds 1% of the market, with increasing investments in shrimp health management. More than 45% of North American shrimp producers prioritize regulatory compliance, driving steady adoption of disease diagnostics technologies across the region.

Europe 

Europe represents 6% of the global shrimp disease diagnostics market, with growing interest in sustainable aquaculture and disease management practices. The United Kingdom holds nearly 2% of the regional share, supported by government-led aquaculture research programs. Norway and Denmark collectively contribute 2%, focusing on disease-free shrimp imports and controlled farming systems. Germany and France account for 1% each, driven by academic research and partnerships with diagnostic manufacturers. Over 40% of European shrimp stakeholders implement biosecurity and monitoring protocols. The region’s demand for eco-friendly and certified shrimp products continues to rise, boosting the use of diagnostic tools by nearly 35% in recent years.

Asia-Pacific 

Asia-Pacific leads the shrimp disease diagnostics market with 60% share, driven by the world’s largest shrimp farming industries. China, India, and Vietnam collectively hold over 48% of the regional market, with China contributing 18%, India 16%, and Vietnam 14%. Thailand and Indonesia account for 8% combined, supported by large-scale aquaculture operations. More than 55% of shrimp farmers in Asia-Pacific use PCR-based diagnostic kits to prevent viral outbreaks like WSSV and TSV. Biosecurity adoption in the region has increased by 40%, while demand for point-of-care testing kits has grown by 35%. Regional government support and industry collaboration strengthen Asia-Pacific’s dominance in shrimp disease diagnostics.

Middle East & Africa 

Middle East & Africa holds 2% of the global shrimp disease diagnostics market, with growing investments in aquaculture diversification. The United Arab Emirates and Saudi Arabia contribute 1% collectively, focusing on improving domestic shrimp production. South Africa holds 0.5% share, supported by government programs promoting aquaculture expansion. Egypt accounts for 0.5%, targeting disease management in coastal aquafarms. Over 30% of shrimp farms in the region have adopted biosecurity protocols, while demand for affordable diagnostic kits has grown by 25%. The region’s focus on food security and reducing seafood imports is expected to boost shrimp disease diagnostics adoption by another 20% in the coming years.

List of Key Company Profiles

Investment Analysis and Opportunities

The shrimp disease diagnostics market is attracting increasing investment, with over 45% of the funding focused on molecular diagnostic platforms like PCR and LAMP. More than 38% of investors are targeting the Asia-Pacific region, driven by the region’s dominance in shrimp production. Aquaculture companies have increased their diagnostic testing budgets by 35%, aiming to improve early disease detection and reduce mortality rates. Strategic partnerships between diagnostic developers and shrimp farming associations have risen by 30%, aimed at expanding distribution networks and enhancing product accessibility. More than 42% of investors are supporting the development of low-cost diagnostic kits to serve emerging markets.

Government funding has increased by 28% to strengthen aquaculture biosecurity programs, encouraging the adoption of diagnostic tools among small and medium shrimp farmers. International organizations have launched awareness campaigns covering over 40% of shrimp-producing regions to promote early disease management. Private investors have increased their stake in diagnostic start-ups by 25%, focusing on next-generation portable kits. Infrastructure expansion in rural shrimp farming areas has risen by 30%, creating new business opportunities for diagnostic service providers. More than 35% of the investments in 2024 targeted research in viral disease detection, strengthening the market’s ability to address major disease outbreaks like WSSV and TSV.

New Products Development

New product development in the shrimp disease diagnostics market is accelerating, with over 40% of manufacturers launching PCR-based kits for specific viral and bacterial diseases. Companies have introduced over 35% more portable diagnostic kits in the last two years, addressing the demand for point-of-care solutions. More than 38% of new products are designed for multi-pathogen detection, allowing shrimp farmers to screen for multiple diseases simultaneously. The adoption of LAMP-based kits has grown by 32%, offering faster results without the need for specialized equipment. Mobile-integrated diagnostic platforms have increased by 28%, providing real-time results to shrimp farmers on-site.

Developers have introduced over 30% more cost-effective diagnostic kits targeting small-scale farmers in Asia-Pacific and Latin America. The market has seen a 25% increase in user-friendly kits that require minimal technical expertise, expanding adoption in remote areas. Customized diagnostic solutions for specific regional pathogens have grown by 20%, addressing local disease challenges. New products with improved sensitivity and accuracy now account for 45% of the product portfolio, ensuring reliable disease detection. Partnerships between research institutes and manufacturers have risen by 30%, driving innovation in advanced diagnostic technologies to meet the growing needs of the global shrimp farming industry.

Recent Developments by Manufacturers 

• Thermo Fisher Scientific launched a new PCR-based shrimp disease detection kit in 2023, increasing market reach by 22% among commercial shrimp farms.
• GeneReach Biotechnology Corp. introduced a portable LAMP-based diagnostic device in 2023, resulting in a 25% increase in sales to small-scale farmers across Southeast Asia.
• Speedy Assay Sdn Bhd expanded its product portfolio in 2024 by adding a multi-pathogen detection kit, boosting customer adoption by 18% in Latin America.
• HiMedia Laboratories developed a cost-effective point-of-care testing solution in 2024, achieving 20% market penetration in rural aquaculture areas.
• Genics announced a strategic partnership with shrimp farming cooperatives in 2024, expanding its diagnostic service network by 30% in the Asia-Pacific region.

Report Coverage 

The shrimp disease diagnostics market report covers all key market dynamics, including drivers, restraints, opportunities, and challenges. Over 60% of the report content is dedicated to analyzing the impact of major shrimp diseases like WSSV, TSV, EMS, and EHP on global shrimp farming. The report includes market segmentation by type and application, with over 50% of the analysis focused on molecular diagnostic tools such as PCR and LAMP. It highlights regional market performance, with Asia-Pacific holding 60% share, followed by Latin America at 20%.

Competitive analysis features over 12 key companies, with Thermo Fisher Scientific and GeneReach Biotechnology Corp. leading with 28% and 22% market shares, respectively. The report provides over 35% coverage on investment trends, government initiatives, and biosecurity programs. It outlines more than 30% of the market focus on point-of-care and portable diagnostic kits. The report further includes a detailed analysis of product developments, representing over 40% of the industry’s growth strategies. Strategic partnerships and technological innovations contributing to 30% of the market advancements are also thoroughly examined.